J&J to sell Millennium cancer drug overseas

Johnson & Johnson has reached a deal with Millennium Pharmaceuticals, offering the Cambridge, Mass.-based company up to $750 million to market its cancer drug Velcade overseas. Analysts say Johnson & Johnson is trying to build its cancer drug business.

View Full Article in:

NYTimes.com · Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ